Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, RXO Inc (NYSE: RXO) closed at $15.44 down -6.20% from its previous closing price of $16.46. In other words, the price has decreased by -$6.20 from its previous closing price. On the day, 1.64 million shares were traded. RXO stock price reached its highest trading level at $16.79 during the session, while it also had its lowest trading level at $15.26.
Ratios:
For a deeper understanding of RXO Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.30 and its Current Ratio is at 1.30. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.37.
On March 13, 2025, Truist started tracking the stock assigning a Buy rating and target price of $24.
On March 07, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $19.Deutsche Bank initiated its Hold rating on March 07, 2025, with a $19 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’25 when Szlosek Thomas A bought 7,500 shares for $16.65 per share. The transaction valued at 124,875 led to the insider holds 16,200 shares of the business.
Szlosek Thomas A bought 8,700 shares of RXO for $125,354 on May 09 ’25. The Director now owns 8,700 shares after completing the transaction at $14.41 per share. On Nov 12 ’24, another insider, Nettles Michelle, who serves as the Director of the company, bought 1,800 shares for $27.89 each. As a result, the insider paid 50,202 and bolstered with 15,185 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXO now has a Market Capitalization of 2530862848 and an Enterprise Value of 3199865088. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.50 while its Price-to-Book (P/B) ratio in mrq is 1.59. Its current Enterprise Value per Revenue stands at 0.631 whereas that against EBITDA is 26.015.
Stock Price History:
The Beta on a monthly basis for RXO is 1.56, which has changed by -0.5051282 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, RXO has reached a high of $32.82, while it has fallen to a 52-week low of $12.19. The 50-Day Moving Average of the stock is -4.40%, while the 200-Day Moving Average is calculated to be -26.45%.
Shares Statistics:
For the past three months, RXO has traded an average of 1.72M shares per day and 1407750 over the past ten days. A total of 163.91M shares are outstanding, with a floating share count of 160.59M. Insiders hold about 2.03% of the company’s shares, while institutions hold 106.20% stake in the company. Shares short for RXO as of 1752537600 were 7386234 with a Short Ratio of 4.28, compared to 1749772800 on 8730976. Therefore, it implies a Short% of Shares Outstanding of 7386234 and a Short% of Float of 12.61.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
